Amina Ahmed1, Wei Deng2, William Tew3, David Bender4, Robert S Mannel5, Ramey D Littell6, Albert S DeNittis7, Mitchell Edelson8, Mark Morgan9, Jay Carlson10, Christopher J Darus11, Aimee C Fleury12, Susan Modesitt13, Alexander Olawaiye14, Anthony Evans15, Gini F Fleming16. 1. Department of OB/GYN, Division of Gyn Oncology, Rush University Medical Center, Chicago, IL 60612, United States. Electronic address: amina_ahmed@rush.edu. 2. NRG Oncology, Clinical Trial Development Division, Biostatistics & Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY 4263, United States. Electronic address: wdeng@gogstats.org. 3. Department of Internal Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, United States. Electronic address: teww@mskcc.org. 4. Gyn/Onc Division, University of Iowa, Iowa City, IA 52242, United States. Electronic address: david-bender@uiowa.edu. 5. Department of OB/GYN, University of Oklahoma, Oklahoma City, OK 73190, United States. Electronic address: Robert-Mannel@ouhsc.edu. 6. Kaiser Permanente Northern California Gynecologic Cancer Program, San Francisco, CA 94115, United States. Electronic address: ramey.littell@kp.org. 7. Department of Radiation Oncology, Main Line Hospital, Wynnewood, PA 19096, United States. Electronic address: dnittisa@mlhs.org. 8. Hanjani Institute for Gynecologic Oncology, Abington Hospital, Jefferson Health, Abington, PA 19001, United States. Electronic address: mitchell.edelson@jefferson.edu. 9. Department of OB/GYN, University of Pennsylvania Hospital System, Philadelphia, PA 19104, United States. Electronic address: mark.a.morgan@uphs.upenn.edu. 10. Cancer Research for the Ozarks, Springfield, MO 65804, United States. Electronic address: jay.carlson@mercy.net. 11. Division of Gynecologic Oncology, Maine Medical Center, Scarborough, ME 04074, United States. Electronic address: darusc@mmc.org. 12. Department of Gynecologic Oncology, Women's Cancer Center of Nevada, Las Vegas, NV 89169, United States. Electronic address: afleury@wccenter.com. 13. Department of OB/GYN, University of Virginia, Charlottesville, VA 22908, United States. Electronic address: scm6h@virginia.edu. 14. Department of Obstetrics & Gynecology, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, United States. Electronic address: olawaiyea@mail.magee.edu. 15. Marshfield Clinic, OB-GYN Dept, Marshfield, WI 54449, United States. Electronic address: evans.anthony@marshfieldclinic.org. 16. Section of Medical Oncology, University of Chicago, Chicago, IL 60637, United States. Electronic address: gfleming@medicine.bsd.uchicago.edu.
Abstract
INTRODUCTION: CC-002 is a prospective cooperative group study conducted by NRG Oncology to evaluate whether a pre-operative GA-GYN score derived from a predictive model utilizing components of an abbreviated geriatric assessment (GA) is associated with major post-operative complications in elderly women with suspected ovarian, fallopian tube, primary peritoneal or advanced stage papillary serous uterine (GYN) carcinoma undergoing primary open cytoreductive surgery. METHODS: Patients 70 years or older with suspected advanced gynecologic cancers undergoing evaluation for surgery were eligible. A GA-GYN score was derived from a model utilizing the GA as a pre-operative tool. Patients were followed for six weeks post-operatively or until start of chemotherapy. Post-operative events were recorded either directly as binary occurrence (yes or no) using CTCAE version 4.0. RESULTS: There were 189 eligible patients, 117 patients with primary surgical intervention and 37 patients undergoing interval cytoreduction surgery. The association between higher GA-GYN score and major postoperative complications in patients undergoing primary surgery was not significant (p = 0.1341). In a subgroup analysis of patients with advanced staged malignant disease who underwent primary cytoreductive surgery, there was a trend towards an association with the GA-GYN score and post-operative complications. CONCLUSION: The pre-operative GA-GYN score derived from a predictive model utilizing components of an abbreviated geriatric assessment was not predictive of major post-operative complications in elderly patients undergoing primary open cytoreductive surgery. However, there was an association between GA-GYN score and post-operative complications in a subgroup of patients with advanced staged malignant disease.
INTRODUCTION: CC-002 is a prospective cooperative group study conducted by NRG Oncology to evaluate whether a pre-operative GA-GYN score derived from a predictive model utilizing components of an abbreviated geriatric assessment (GA) is associated with major post-operative complications in elderly women with suspected ovarian, fallopian tube, primary peritoneal or advanced stage papillary serous uterine (GYN) carcinoma undergoing primary open cytoreductive surgery. METHODS:Patients 70 years or older with suspected advanced gynecologic cancers undergoing evaluation for surgery were eligible. A GA-GYN score was derived from a model utilizing the GA as a pre-operative tool. Patients were followed for six weeks post-operatively or until start of chemotherapy. Post-operative events were recorded either directly as binary occurrence (yes or no) using CTCAE version 4.0. RESULTS: There were 189 eligible patients, 117 patients with primary surgical intervention and 37 patients undergoing interval cytoreduction surgery. The association between higher GA-GYN score and major postoperative complications in patients undergoing primary surgery was not significant (p = 0.1341). In a subgroup analysis of patients with advanced staged malignant disease who underwent primary cytoreductive surgery, there was a trend towards an association with the GA-GYN score and post-operative complications. CONCLUSION: The pre-operative GA-GYN score derived from a predictive model utilizing components of an abbreviated geriatric assessment was not predictive of major post-operative complications in elderly patients undergoing primary open cytoreductive surgery. However, there was an association between GA-GYN score and post-operative complications in a subgroup of patients with advanced staged malignant disease.
Authors: Arti Hurria; Kayo Togawa; Supriya G Mohile; Cynthia Owusu; Heidi D Klepin; Cary P Gross; Stuart M Lichtman; Ajeet Gajra; Smita Bhatia; Vani Katheria; Shira Klapper; Kurt Hansen; Rupal Ramani; Mark Lachs; F Lennie Wong; William P Tew Journal: J Clin Oncol Date: 2011-08-01 Impact factor: 44.544
Authors: Ignace Vergote; Claes G Tropé; Frédéric Amant; Gunnar B Kristensen; Tom Ehlen; Nick Johnson; René H M Verheijen; Maria E L van der Burg; Angel J Lacave; Pierluigi Benedetti Panici; Gemma G Kenter; Antonio Casado; Cesar Mendiola; Corneel Coens; Leen Verleye; Gavin C E Stuart; Sergio Pecorelli; Nick S Reed Journal: N Engl J Med Date: 2010-09-02 Impact factor: 91.245
Authors: Dennis S Chi; Fernanda Musa; Fanny Dao; Oliver Zivanovic; Yukio Sonoda; Mario M Leitao; Douglas A Levine; Ginger J Gardner; Nadeem R Abu-Rustum; Richard R Barakat Journal: Gynecol Oncol Date: 2011-09-13 Impact factor: 5.482
Authors: Arti Hurria; Constance T Cirrincione; Hyman B Muss; Alice B Kornblith; William Barry; Andrew S Artz; Linda Schmieder; Rafat Ansari; William P Tew; Douglas Weckstein; Jeffrey Kirshner; Kayo Togawa; Kurt Hansen; Vani Katheria; Richard Stone; Ilene Galinsky; John Postiglione; Harvey Jay Cohen Journal: J Clin Oncol Date: 2011-02-28 Impact factor: 44.544
Authors: Giovanni D Aletti; Eric L Eisenhauer; Antonio Santillan; Allison Axtell; Giacomo Aletti; Christine Holschneider; Dennis S Chi; Robert E Bristow; William A Cliby Journal: Gynecol Oncol Date: 2010-10-08 Impact factor: 5.482
Authors: Israel Zighelboim; Nora Kizer; Nicholas P Taylor; Ashley S Case; Feng Gao; Premal H Thaker; Janet S Rader; L Stewart Massad; David G Mutch; Matthew A Powell Journal: Gynecol Oncol Date: 2009-12-16 Impact factor: 5.482
Authors: R A Audisio; D Pope; H S J Ramesh; R Gennari; B L van Leeuwen; C West; G Corsini; M Maffezzini; H J Hoekstra; D Mobarak; F Bozzetti; M Colledan; H Wildiers; A Stotter; A Capewell; E Marshall Journal: Crit Rev Oncol Hematol Date: 2007-12-21 Impact factor: 6.312
Authors: Clark DuMontier; Mina S Sedrak; Wee Kheng Soo; Cindy Kenis; Grant R Williams; Kristen Haase; Magnus Harneshaug; Hira Mian; Kah Poh Loh; Siri Rostoft; William Dale; Harvey Jay Cohen Journal: J Geriatr Oncol Date: 2019-08-23 Impact factor: 3.599
Authors: Olga T Filippova; Dennis S Chi; Kara Long Roche; Yukio Sonoda; Oliver Zivanovic; Ginger J Gardner; William P Tew; Roisin O'Cearbhaill; Saman Sarraf; Sung Wu Sun; Koshy Alexander; Beatriz Korc-Grodzicki; Armin Shahrokni Journal: Gynecol Oncol Date: 2019-05-08 Impact factor: 5.482
Authors: Ying L Liu; Olga T Filippova; Qin Zhou; Alexia Iasonos; Dennis S Chi; Oliver Zivanovic; Yukio Sonoda; Ginger J Gardner; Vance A Broach; Roisin E O'Cearbhaill; Jason A Konner; Carol Aghajanian; Kara Long Roche; William P Tew Journal: J Gynecol Oncol Date: 2020-01 Impact factor: 4.401